HIV :: Merck lowers HIV drug Atripla price for developing countries

Merck & Co., Inc. announced that it has begun to file registrations for ATRIPLA? (efavirenz 600 mg/ emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), a once-daily, single tablet regimen for the treatment of HIV-1 infection in adults, with health authorities in those developing countries around the world where many HIV-positive people live.

Salmonella :: Salmonella cases linked to peanut butter – PA

Due to risk of contamination with salmonella, PA state Health Secretary Dr. Calvin B. Johnson today advised consumers not to eat and to discard Peter Pan Peanut Butter and Great Value Peanut Butter with product codes that begin with the number ?2111.?

HIV :: Researchers discover new details about HIV-1 entry and infection

The primary targets of HIV-1 infection in the human vagina have been definitively identified in a new study published in the February 2007 issue of the journal Immunity, published by Cell Press. The findings are likely to guide development of new strategies that will prevent HIV-1 transmission.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | Health Newstrack